Brookline, MA, United States of America

Jan Kajstura

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Boston, MA (US) (2013)
  • Brookline, MA (US) (2012 - 2014)
  • New York, NY (US) (2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Jan Kajstura: Pioneering Cardiac Regenerative Treatments

Introduction

Jan Kajstura, an accomplished inventor based in Brookline, MA, has made significant contributions to the field of cardiac regenerative medicine. With a total of eight patents to his name, his work focuses on developing advanced methods for isolating and utilizing cardiac stem cells, showing promise for treating various heart conditions.

Latest Patents

Kajstura's latest patents include groundbreaking inventions such as methods for isolating non-senescent cardiac stem cells and their applications. This invention describes a pioneering technique to isolate a pool of adult cardiac stem cells that exhibit superior regenerative capacity. Remarkably, these cells boast immortal DNA, allowing for potential longevity in therapeutic applications.

Another patent showcases compositions comprising adult cardiac vascular progenitor cells (VPCs) and adult cardiac myocyte progenitor cells (MPCs). This invention outlines methods for generating biological bypasses, repairing damaged myocardium, and treating conditions like hypertensive cardiomyopathy and heart failure, further demonstrating the potential of Kajstura's innovations in advancing cardiac treatment.

Career Highlights

Throughout his career, Jan Kajstura has collaborated with esteemed organizations such as New York Medical College and Autologous, LLC. His contributions have been instrumental in advancing techniques that enhance the regenerative capacity of cardiac tissues, ultimately aiming to improve patient outcomes in cardiac care.

Collaborations

In his research endeavors, Kajstura has worked alongside prominent colleagues, including Piero Anversa and Annarosa Leri. Their collaborative efforts have further enriched the field of cardiac regenerative medicine, fostering innovations that address critical health challenges.

Conclusion

Jan Kajstura stands out as a key innovator in the realm of cardiac regenerative therapies. His patents reflect a commitment to unlocking the potential of cardiac stem cells, paving the way for future advancements in the treatment of heart diseases. Through his dedicated work and collaborations, Kajstura continues to influence the landscape of regenerative medicine significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…